“Peritoneum”的搜索结果，显示 101-110 项，共有 13043 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Cohort C: Triple-negative breast cancer (TNBC);; Cohort D: Platinum-resistant/refractory epithelial ovarian, primary peritoneal, or fallopian tube cancer ( ...

2. 外科 - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the safety of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in 2 groups of patients with peritoneal ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Establish a prospective database of all patients with peritoneal surface malignancies seen by Dr. Travis Grotz at the Mayo Clinic, Rochester. Design and ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... peritoneal metastasis and/or positive peritoneal cytology undergoing robotic cytoreduction and hyperthermic intraperitoneal chemotherapy. IMC-F106C Regimen ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Cohort C: Triple-negative breast cancer (TNBC);; Cohort D: Platinum-resistant/refractory epithelial ovarian, primary peritoneal, or fallopian tube cancer ( ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to evaluate the reduction in the peritoneal carcinomatosis index (PCI) after completion of the study treatment.

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to evaluate the reduction in the peritoneal carcinomatosis index (PCI) after completion of the study treatment.

8. 腹膜转移癌- 在 Mayo Clinic 治疗 - 妙佑医疗国际

   这种癌症通常起源于其他器官，然后扩散至腹腔内膜。了解症状和治疗方案，包括可能带来更多希望的新方法。

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to evaluate the reduction in the peritoneal carcinomatosis index (PCI) after completion of the study treatment.

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Rochester, Minn. The purpose of this study is to evaluate the reduction in the peritoneal carcinomatosis index (PCI) after completion of the study treatment.